CervoMed Inc.

CRVO

CervoMed Inc.

CRVO

Insider Sentiment (TTM):

Last Purchase:2026-06-11Last Sale:2024-02-26Shares Purchased (TTM):1,009,020Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,769,604Shares Outstanding:9,258,319Institutional Ownership Pct.:19.11%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	22	8	8	9	8	11	9	8	10	6	8	10
Marketable Securities Current	2	5	13	18	25	25	30	39	35	-	0	-
Deferred Offering Costs	0	0	0	0	0	-	0	-	-	0	-	-
Grants Receivable Current	0	0	0	1	2	2	2	0	0	0	1	-
Other Assets Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Assets Current	26	15	23	31	38	39	43	49	47	8	10	12
Marketable Securities Noncurrent	-	-	-	-	-	-	-	-	6	-	-	-
Assets	26	15	23	31	38	39	43	49	53	8	10	12
Liabilities Current
Convertible Notes Payable Current	-	-	-	-	-	-	-	-	-	-	0	0
Accounts Payable Current	1	2	1	1	2	2	2	1	1	1	1	1
Deferred Revenue Current	-	-	-	-	-	-	-	-	1	1	-	1
Other Accrued Liabilities Current	-	-	3	-	-	2	2	2	1	1	2	1
Liabilities Current	-	-	5	-	-	-	4	-	-	-	-	-
Liabilities	3	4	5	5	5	4	4	3	3	3	3	2
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	-	0	0
Stockholders Equity
Preferred Stock Value	-	-	-	-	-	-	-	-	-	0	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	135	116	116	116	115	110	110	110	109	62	62	62
Accumulated Other Comprehensive Income Loss Net Of…	0	-0	0	0	-0	0	0	0	-0	-	0	-
Retained Earnings Accumulated Deficit	-112	-106	-98	-90	-82	-76	-71	-64	-59	-57	-54	-52
Stockholders Equity	23	11	18	26	33	35	39	46	50	5	7	10
Liabilities And Stockholders Equity	26	15	23	31	38	39	43	49	53	8	10	12
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	0.001	-	-
Preferred Stock Shares Authorized	-	-	-	-	-	-	-	-	-	30	-	30
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	-	-	0	-	-
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	0	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Shares Outstanding	14	9	9	9	9	9	9	8	8	6	6	6
Common Stock Shares Issued	14	9	9	9	9	9	9	8	8	6	6	6

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.53%	3.20%	-25.00%	-	-	-	-	-	-	-	-	-
2025	-16.26%	-37.91%	-2.97%	-2.34%	-15.94%	-28.22%	43.64%	16.76%	-9.25%	-2.59%	-12.71%	-26.82%
2024	-22.31%	-37.25%	-56.96%	65.07%	34.13%	21.45%	0.68%	-80.30%	-80.90%	-6.19%	-6.19%	-15.80%
2023	-	-	-	18.40%	-5.52%	73.42%	-4.93%	-3.39%	-16.14%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	-	-	4.91	-	-	-	11.11	-	-	-	-	-
Quick Ratio	-	-	4.91	-	-	-	11.11	-	-	-	-	-
Working Capital	-	-	18.22M	-	-	-	39.20M	-	-	-	-	-
Leverage & Debt
Debt to Equity	-	-	0.26	-	-	-	0.10	-	-	-	-	-
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-50.05	-22.11	-17.73
Debt Ratio	-	-	0.20	-	-	-	0.09	-	-	-	-	-
Efficiency & Turnover
Asset Turnover TTM	0.01	0.08	0.12	0.15	0.17	0.40	0.37	0.33	0.18	1.35	1.01	0.24
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-	-	-	-1.27	-	-	-	0.32
Free Cash Flow Per Share TTM	-2.73	-2.98	-2.59	-2.69	-2.60	-2.18	-2.05	-1.27	-0.88	-1.20	-2.80	-1.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-9,406.96%	-1,488.86%	-706.22%	-441.64%	-315.76%	-224.91%	-187.18%	-133.78%	-111.32%	-111.10%	-109.35%	-358.90%
Net Profit Margin TTM	-9,160.94%	-1,437.83%	-673.06%	-351.37%	-290.75%	-200.58%	-167.29%	-109.83%	-52.24%	-51.36%	-30.40%	26.26%
Growth Metrics
Net Revenue Growth (1Y)	-95.74%	-77.56%	-58.86%	-38.81%	-19.44%	15.14%	36.29%	116.29%	208.63%	474.22%	-	-
Net Income Growth (1Y)	34.22%	60.88%	65.53%	95.77%	348.36%	349.69%	650.08%	-1,004.55%	-628.50%	129.29%	-62.57%	-109.65%
EPS Growth (1Y)	17.27%	51.22%	47.80%	84.13%	335.95%	218.84%	147.27%	-443.86%	-131.47%	-80.75%	-92.71%	-101.51%
Valuation Metrics
P/E TTM	-1.05	-1.21	-2.65	-3.46	-2.49	-4.27	-1.16	-11.49	-29.54	-34.63	-9.35	12.51
P/B TTM	1.38	3.44	3.92	2.88	1.68	2.30	0.48	2.78	2.98	26.94	2.75	1.60
P/S TTM	95.86	17.46	17.83	12.15	7.24	8.55	1.94	12.62	15.43	17.78	2.84	3.28
Market Cap	31.76M	36.48M	71.43M	74.85M	56.30M	79.63M	18.89M	127.06M	148.99M	143.77M	20.31M	15.28M
Enterprise Value	9.30M	28.54M	63.19M	65.42M	47.98M	69.13M	9.89M	119.32M	138.98M	137.40M	12.51M	4.86M
Calculated Values
Free Cash Flow TTM	-27.98M	-27.57M	-23.45M	-24.93M	-23.31M	-19.00M	-16.53M	-11.02M	-7.63M	-7.39M	-7.45M	-5.60M
Net Debt	-22.46M	-7.94M	-8.24M	-9.44M	-8.32M	-10.50M	-9.00M	-7.74M	-10.01M	-6.37M	-7.79M	-10.42M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Purchase

Owner: Boger, Joshua S

Title: -

Shares: 955,414

Price/Share: $3.14

Value: $2,999,999.96

Shares Owned: 1,795,865

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-11-18Purchase

Owner: Elder, William Robert

Title: CFO, GC & Secretary

Shares: 2,500

Price/Share: $8.32

Value: $20,800.00

Shares Owned: 12,500

Relationship: Officer

Ownership: Direct

2025-11-18Purchase

Owner: Winton, Matthew

Title: Chief Commercial and Business

Shares: 1,500

Price/Share: $7.95

Value: $11,925.00

Shares Owned: 15,000

Relationship: Officer

Ownership: Direct

2025-11-17Purchase

Owner: Gregoire, Sylvie

Title: -

Shares: 10,793

Price/Share: $8.46

Value: $91,308.78

Shares Owned: 1,484,078

Relationship: Director,TenPercentOwner

Ownership: Direct

2025-11-17Purchase

Owner: Alam, John J

Title: CEO & President

Shares: 10,807

Price/Share: $8.46

Value: $91,427.22

Shares Owned: 1,484,078

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Boger, Joshua S	Director,TenPercentOwner	-	Indirect	Purchase	955,414	3.14	$2,999,999.96	1,795,865	4
2025-11-18	Elder, William Robert	Officer	CFO, GC & Secretary	Direct	Purchase	2,500	8.32	$20,800.00	12,500	4
2025-11-18	Winton, Matthew	Officer	Chief Commercial and Business	Direct	Purchase	1,500	7.95	$11,925.00	15,000	4
2025-11-17	Gregoire, Sylvie	Director,TenPercentOwner	-	Direct	Purchase	10,793	8.46	$91,308.78	1,484,078	4
2025-11-17	Alam, John J	Director,Officer,TenPercentOwner	CEO & President	Direct	Purchase	10,807	8.46	$91,427.22	1,484,078	4
2025-11-14	Gregoire, Sylvie	Director,TenPercentOwner	-	Direct	Purchase	1,707	7.57	$12,921.99	1,473,285	4
2025-11-14	Alam, John J	Director,Officer,TenPercentOwner	CEO & President	Direct	Purchase	1,693	7.55	$12,782.15	1,473,271	4
2025-11-14	Winton, Matthew	Officer	Chief Commercial and Business	Direct	Purchase	10,000	7.57	$75,700.00	10,000	4
2025-11-12	Gregoire, Sylvie	Director,TenPercentOwner	-	Direct	Purchase	5,553	7.35	$40,814.55	1,467,131	4
2025-11-12	Alam, John J	Director,Officer,TenPercentOwner	CEO & President	Direct	Purchase	5,553	7.35	$40,814.55	1,467,131	4
2025-11-12	Elder, William Robert	Officer	CFO, GC & Secretary	Direct	Purchase	3,500	7.44	$26,040.00	9,000	4
2025-05-14	Elder, William Robert	Officer	CFO, GC & Secretary	Direct	Purchase	4,233	8.46	$35,811.18	5,500	4
2024-08-27	Elder, William Robert	Officer	CFO & GC	Direct	Purchase	1,000	18.16	$18,160.00	1,267	4
2024-02-26	Boger, Joshua S	Director,TenPercentOwner	-	Indirect	Sale	36	-	-	840,451	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

19.11%

Inst. Shares: 1,769,604

Shares Outstanding: 9,258,319

2025-12-31

24.85%

Inst. Shares: 2,247,126

Shares Outstanding: 9,041,760

2025-09-30

22.91%

Inst. Shares: 2,119,958

Shares Outstanding: 9,252,719

2025-06-30

24.15%

Inst. Shares: 2,161,912

Shares Outstanding: 8,950,521

2025-03-31

26.15%

Inst. Shares: 2,275,833

Shares Outstanding: 8,702,719

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,769,604	9,258,319	19.11%
2025-12-31	2,247,126	9,041,760	24.85%
2025-09-30	2,119,958	9,252,719	22.91%
2025-06-30	2,161,912	8,950,521	24.15%
2025-03-31	2,275,833	8,702,719	26.15%
2024-12-31	1,451,975	8,073,155	17.99%
2024-09-30	3,338,407	8,702,764	38.36%
2024-06-30	3,280,120	8,702,764	37.69%
2024-03-31	2,324,711	6,170,501	37.67%
2023-12-31	259,221	2,661,416	9.74%
2023-09-30	334,463	3,308,302	10.11%
2023-06-30	136,448	518,140	26.33%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CervoMed Inc. (CRVO) — SEC Financial Statements & Analysis

CervoMed Inc. (CRVO) is a pharmaceutical preparations company, incorporated in DE. CervoMed Inc. trades on Nasdaq as: CRVO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CervoMed Inc. reported a -95.74% year-over-year revenue growth, a Debt-to-Equity ratio of 0.26x, a Price-to-Sales (P/S) ratio of 95.86x (TTM), a Price-to-Book (P/B) ratio of 1.38x (TTM), at a market cap of $31.76M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -95.74%
Debt To Equity: 0.26x
P/S TTM: 95.86x
P/B TTM: 1.38x
Market Cap: $31.76M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CervoMed Inc. in?

CervoMed Inc. (CRVO) operates in the Pharmaceutical Preparations industry.

What is CRVO's market cap?

CervoMed Inc. (CRVO) has a market capitalization of $31.76M as of 2026-06-30.

What exchange does CRVO trade on?

CervoMed Inc. (CRVO) trades on the Nasdaq.

Where is CervoMed Inc. incorporated?

CervoMed Inc. is incorporated in DE.

CervoMed Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

CervoMed Inc. (CRVO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

CervoMed Inc. (CRVO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.